EE102 Economic and Organisational Impact of an Innovative Treatment With Extended Durability for Retinal Diseases Reducing the Annual Frequency of Intravitreal Injections in France
Abstract
Authors
G Bourel R Monnier S Ba JP Guillet D Havet S Pibre M Laloux K Le Lay A Roula